Business Context and Reporting Period
This Form 8-K Current Report was filed by Bicycle Therapeutics plc on January 29, 2026. The filing discloses a significant change in executive leadership, specifically the appointment of a new Chief Financial Officer and the departure of the incumbent.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
- Appointment of CFO: Travis Thompson was appointed Chief Financial Officer, effective January 29, 2026, succeeding Alethia Young.
- Departure of CFO: Alethia Young transitioned out of her role as CFO and all other officer roles effective January 29, 2026.
- Interim Transition: Ms. Young will remain in an interim capacity until April 29, 2026, followed by a two-year consulting arrangement.
Guidance, Outlook, and Compensation Details
Travis Thompson (New CFO)
- Base Salary: $500,000 annually.
- Performance Bonus: Target annual cash bonus of 50% of base salary.
- Equity: Option to purchase 58,000 ordinary shares subject to standard vesting.
- Severance: Nine months of base salary and COBRA for termination without cause or for good reason. In the event of a change in control within 12 months, benefits increase to 18 months of base salary, full annual bonus, and full acceleration of unvested equity.
Alethia Young (Outgoing CFO)
- Transition Period Pay: Base salary continues through April 29, 2026.
- Severance: Nine months of base salary following the separation date.
- Bonuses: Full 2025 annual cash bonus (target achievement) and a pro-rated 2026 bonus (1/4 of target).
- Consulting Fee: $2,000 per day for up to five days per month, effective April 29, 2026, for a two-year term with automatic renewal.
Investor Verification Checklist
- Verify the full text of the Employment Agreement, Separation Agreement, and Consulting Agreement when filed in the Form 10-Q for the period ending March 31, 2026.
- Confirm the vesting schedule details for Mr. Thompson's 58,000 share options.
- Monitor the company's cash burn rate given the immediate cash outflows for Ms. Young's severance and bonus payments.
- Review the definition of "good reason" and "without cause" in the new CFO's agreement to understand potential future liability triggers.